Lina Khan Takes Parting Shots at Big Pharma and Big Rent

REGULATION

Vaccine Stocks Caught the Bird Flu Bug, But Reality is Biting

BANKING

Walgreens Sells Itself to Sycamore... Not Amazon

PRIVATE EQUITY

Healthcare's CEOs' Reveal Sky-High Compensation

HEALTHCARE

Eli Lilly: The Biggest Threat to Ozempic

Price Target: $700 (19% upside)

MorphoSys: A New Biotech Play

Price Target: $10 (25% upside)

Intellia: Is Gene Editing The Future of Medicine?

Price Target: $44 (30% upside)

Eli Lilly's Chronic Pincer Move

Elevance Health: Profiting from the Wealthiest Generation

Price Target: $554 (18% upside)

Shockwave: The Sleeper in Biotech

Evotec: The Best AI Healthcare Play

AstraZeneca's AI Cancer Missiles

Price Target: $88 (19% upside)

How Eli Lilly is Abolishing Obesity

Price Target: $483 (15% upside)

Merck's Secret Weapon Against Cancer

Price Target: $140 (21% upside)

Intuitive Surgical: The Right Growth at the Right Time

Price Target: $340 (16% upside)

Illumina: A Famous Activist Coming Aboard

Zoetis: Diversified and Poised for Growth

Merck: Getting Closer To Solving Cancer

Intuitive Surgical: A Strong Return to Medical Normal

Eli Lilly: The Biggest Healthcare Advancement In A Decade

Illumina is About to Corner the DNA Market

Biogen: A Crossroads to Complete our Pharma Trifecta

Eli Lilly: A Solid Discount Before the Big Show

Price Target: $388 (28% upside)

Thermo Fischer Scientific: Pivoting to Growth

Price Target: $689 (21% upside)